Botulinum toxin for achalasia: are we asking the right questions?
Hoogerwerf
W A
WA
Division of Gastroenterology and Hepatology, University of Taxas Medical Branch, Galveston, USA.
Pasricha
P J
PJ
D018726:Anti-Dyskinesia Agents / Q000627:therapeutic use*; D001905:Botulinum Toxins / Q000627:therapeutic use*; D004931:Esophageal Achalasia / Q000188:drug therapy*; D006801:Humans
D018726:Anti-Dyskinesia Agents; D001905:Botulinum Toxins